Wildcat Capital Management, LLC 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 4:15 pm Sale |
2021-12-31 | 13G | UroGen Pharma Ltd. URGN |
Wildcat Capital Management, LLC | 533,139 2.400% |
-719,146![]() (-57.43%) |
Filing |
2021-02-12 4:10 pm Purchase |
2020-12-31 | 13G | UroGen Pharma Ltd. URGN |
Wildcat Capital Management, LLC | 1,252,285 5.670% |
96,423![]() (+8.34%) |
Filing |